Listing 1 - 10 of 2746 | << page >> |
Sort by
|
Choose an application
Choose an application
Choose an application
Choose an application
Choose an application
This 2023 Article IV Consultation discusses that the economic recovery in Hong Kong Special Administrative Region (SAR) stalled in 2022 following a major coronavirus disease 2019 outbreak and U.S. monetary policy tightening. However, in 2023, real gross domestic product is projected to grow by 3.5 percent. The financial system remains resilient and continues to serve as an international financial center, supported by strong institutional frameworks and substantial capital and liquidity buffers. The Linked Exchange Rate System continues to function smoothly, providing a solid anchor to the economy and the financial system, allowing the latter to perform its role as an international financial center. Housing prices, which declined by about 16 percent by end-2022 from the peak in September 2021, have started to recover in early 2023. Near-term risks to the growth outlook are balanced, with systemic risk in the financial sector manageable given significant buffers. A sharper-than-expected global growth slowdown as well as escalation of regional conflicts and resulting disruptions in trade could derail the recovery. A sharp rise in global risk premia amid renewed stress in the global banking system and further tightening of monetary policy in major advanced economies could have adverse spillovers through financial channels.
Choose an application
China --- demography --- statistics --- the People's Republic of China
Choose an application
Choose an application
Japan --- China --- China (People's Republic of China, 1949- ) --- History.
Choose an application
This volume provides a comprehensive review of China's healthcare system and policy reforms in the context of the global economy. Following a value-chain framework, the 16 chapters cover the payers, the providers, and the producers (manufacturers) in China's system. It also provides a detailed analysis of the historical development of China's healthcare system, the current state of its broad reforms, and the uneasy balance between China's market-driven approach and governmental regulation. Most importantly, it devotes considerable attention to the major problems confronting China, including chronic illness, public health, and long-term care and economic security for the elderly. Burns and Liu have assembled the latest research from leading health economists and political scientists, as well as senior public health officials and corporate executives, making this book an essential read for industry professionals, policymakers, researchers, and students studying comparative health systems across the world.
Medical care --- China --- Mainland China --- Inner Mongolia --- Manchuria --- People's Republic of China --- Sinkiang
Choose an application
Artemisinin. --- Antimalarials --- Peroxides --- Sesquiterpenes --- China. --- Mainland China --- Inner Mongolia --- Manchuria --- People's Republic of China --- Sinkiang
Listing 1 - 10 of 2746 | << page >> |
Sort by
|